Navigation Links
New research changes understanding of C4 plant evolution
Date:11/15/2010

Frostburg, Md. (November 15, 2010) A new analysis of fossilized grass-pollen grains deposited on ancient European lake and sea bottoms 16-35 million years ago reveals that C4 grasses evolved earlier than previously thought. This new evidence casts doubt on the widely-held belief that the rise of this incredibly productive group of plants was driven by a large drop in atmospheric carbon dioxide concentrations during the Oligocene epoch.

The research team, led by University of Maryland Center for Environmental Science Appalachian Laboratory researcher Dr. David Nelson and University of Illinois Professor Feng Sheng Hu, examined the carbon isotope signatures of hundreds of grass-pollen grains and found that C4 grasses were already present on the landscape during the early part of the Oligocene, some 14 million years earlier than previously thought from geological evidence. Their findings are now published online in the journal Geology and will shortly appear in the print edition.

"The idea that C4 grasses originated prior to global decreases in carbon dioxide levels requires us to reevaluate the way we think about the evolution of C4 photosynthesis," said Dr. Nelson. "This new information should encourage the examination of alternate evolutionary selection pressures, such as warm temperatures or dry climates."

C4 plants compose only 3 percent of flowering plant species, yet account for about 25 percent global terrestrial productivity. About 60% of C4 species are grasses, and they dominate the world's grassland and savanna biomes, particularly those in warmer, lower latitude areas. Their ecological success results from the way these species concentrate and then fix carbon dioxide in order to power photosynthesis. While the most well known C4 plants are maize and sugar cane, both of which are critical to human consumption, there is a growing interest in their use as biofuels in order to capture carbon from the atmosphere to mitigate increasing global carbon dioxide levels.

The team used an innovative technique pioneered by Dr. Nelson earlier in his career - the Single Pollen Isotope Ratio Analysis or SPIRAL to analyze the samples. The scientists first extracted grains of grass pollen from sedimentary rocks using a micromanipulator; then analyzed the tiny samples using a microcombustion device interfaced with an isotope ratio mass spectrometer in Ann Pearson's laboratory at Harvard University, which houses one of only a handful of these devices in the world. Through this analysis, they were able to detect the signature of C4 species from their more common C3 counterparts, because C4 and C3 plants take up different ratios of carbon isotopes during photosynthesis.

"SPIRAL enables us to detect C4 grasses at much lower abundances in geological records than previous approaches, which is helping to revolutionize our ability to study their ecology and evolution," said Dr. Hu. University of Illinois graduate student Michael Urban, lead author of the paper, continues to analyze samples from other parts of the world to look at variation in C4-grass abundance in relation to past changes in atmospheric CO2 and climate.


'/>"/>

Contact: Christopher Conner
cconner@umces.edu
443-496-0095
University of Maryland Center for Environmental Science
Source:Eurekalert

Related biology news :

1. Tufts University chemist earns prestigious award for promising research on drug development
2. Clemson researcher will study plutonium underground for Energy Department
3. LSU oceanography researcher discovers toxic algae in open water
4. Medical research and magic come together
5. Scripps Research scientists identify new mechanism regulating daily biological rhythms
6. Sickle cell disease and its link to race focus of NJIT researcher at NIH event
7. Research provides new leads in the case against drug-resistant biofilms
8. U of A researchers can predict heart transplant patients health earlier
9. Gates Foundation continues funding of tuberculosis research at Weill Cornell
10. Einstein researcher receives American Cancer Society Medal of Honor
11. Viertel Foundation Fellowship for leading cancer researcher
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology: